← Browse by Condition
Medical Condition
pulmonary arterial hypertension
Total Trials
7
Recruiting Now
7
Trial Phases
Phase 1, Phase 2
NCT06429930 Phase 1
Recruiting
Safety, Tolerability and Pharmacokinetics Study of L608 in Healthy Adults
Enrollment
32 pts
Location
New Zealand
Sponsor
Pharmosa Biopharm Inc.
NCT05464095
Recruiting
The MObile Health InterVEntion in Pulmonary Arterial Hypertension (MOVE PAH) Study
Enrollment
100 pts
Location
United States
Sponsor
Vanderbilt University Medical ...
NCT04972656
Recruiting
Treatment With Ambrisentan in Patients With Borderline Pulmonary Arterial Hypertension
Enrollment
420 pts
Location
China
Sponsor
Nanjing First Hospital, Nanjin...
NCT02845518
Recruiting
Study of Cardiac MRI in the Follow up Assessment of Patients With PAH (EVITA)
Enrollment
180 pts
Location
France
Sponsor
Central Hospital, Nancy, Franc...
NCT06605794
Recruiting
FreeFlow Percutaneous Atrial Septal Shunt for IPAH
Enrollment
30 pts
Location
China
Sponsor
Shanghai Zhongshan Hospital
NCT01712620 Phase 2
Recruiting
Spironolactone for Pulmonary Arterial Hypertension
Enrollment
70 pts
Location
United States
Sponsor
National Institutes of Health ...
NCT04808596
Recruiting
Pulmonary Hypertension Biorepository and Registry
Enrollment
300 pts
Location
United States
Sponsor
University of Kansas Medical C...